For patients with opioid use disorder taking buprenorphine-naloxone, it is deemed appropriate to continue three times-daily dosing

Screening protocol could identify candidates for neuromodulation therapies who could skip a formal in-person psychological assessment

Group-based CBT intervention produced modest, but sustained, reductions in measures of pain, pain-related disability

66 percent of patients randomly assigned to pain reprocessing therapy were pain-free after treatment compared with 20 percent in placebo group

Sleep disturbance in older adults also more common among those living with a partner and urinating at night

Virtual reality intervention also significantly decreases pain among patients undergoing peripheral IV catheter placement

Findings show noninferior outcomes at three months versus cognitive behavioral therapy

Most patients had co-occurring symptoms: 21.3, 19.1, and 17.4 percent had two, three, and four symptoms, respectively

Worse pain-related physical function, psychosocial functioning, increased health care utilization reported for chronic migraine with overlapping pain